Trevi Therapeutics, Inc.

Q1 2026 13F Holders

Symbol
TRVI
CUSIP
89532M101
Type
Equity
Class
COM
Num filers
201
Total reported value, excl. options
$1.61B
Manager Report Date Value ($000) Shares